Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gema Moreno-Bueno

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Breast Cancer Research : BCR|March 3, 2019
Updating the role of obesity and cholesterol in breast cancerLaura Garcia-Estevez, Gema Moreno-Bueno
The FEBS Journal|November 24, 2023
Gasdermin-B (GSDMB) takes center stage in antibacterial defense, inflammatory diseases, and cancerDavid Sarrio, Sara Colomo, Gema Moreno-Bueno
Cancers|September 23, 2022
Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted DrugsManuel Gámez-Chiachio, David Sarrió, Gema Moreno-Bueno
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|November 26, 2020
Insight updating of the molecular hallmarks in ovarian carcinomaAlba Mota, Sara S Oltra, Gema Moreno-Bueno
Cell Cycle (Georgetown, Tex.)|March 23, 2007
Telling cells how to die: docetaxel therapy in cancer cell linesHéctor Hernández-Vargas, José Palacios, Gema Moreno-Bueno
Cancer Management and Research|May 10, 2014
Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectivesAntonio Díaz-López, Gema Moreno-Bueno, Amparo Cano
Journal of Clinical Medicine|May 17, 2019
Contribution of Epithelial Plasticity to Therapy ResistancePatricia G Santamaría, Gema Moreno-Bueno, Amparo Cano
Future Oncology (London, England)|October 4, 2012
LOXL2 in epithelial cell plasticity and tumor progressionAmparo Cano, Patricia G Santamaría, Gema Moreno-Bueno
Frontiers in Immunology|December 6, 2021
The Leptin Axis and Its Association With the Adaptive Immune System in Breast CancerLaura García-Estevez, Silvia González-Martínez, Gema Moreno-Bueno
Molecular Oncology|June 8, 2017
EMT: Present and future in clinical oncologyPatricia G Santamaria, Gema Moreno-Bueno, Francisco Portillo, et al.
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Breast Cancer Research : BCR|March 3, 2019
Updating the role of obesity and cholesterol in breast cancerLaura Garcia-Estevez, Gema Moreno-Bueno
The FEBS Journal|November 24, 2023
Gasdermin-B (GSDMB) takes center stage in antibacterial defense, inflammatory diseases, and cancerDavid Sarrio, Sara Colomo, Gema Moreno-Bueno
Cancers|September 23, 2022
Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted DrugsManuel Gámez-Chiachio, David Sarrió, Gema Moreno-Bueno
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|November 26, 2020
Insight updating of the molecular hallmarks in ovarian carcinomaAlba Mota, Sara S Oltra, Gema Moreno-Bueno
Cell Cycle (Georgetown, Tex.)|March 23, 2007
Telling cells how to die: docetaxel therapy in cancer cell linesHéctor Hernández-Vargas, José Palacios, Gema Moreno-Bueno
Cancer Management and Research|May 10, 2014
Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectivesAntonio Díaz-López, Gema Moreno-Bueno, Amparo Cano
Journal of Clinical Medicine|May 17, 2019
Contribution of Epithelial Plasticity to Therapy ResistancePatricia G Santamaría, Gema Moreno-Bueno, Amparo Cano
Future Oncology (London, England)|October 4, 2012
LOXL2 in epithelial cell plasticity and tumor progressionAmparo Cano, Patricia G Santamaría, Gema Moreno-Bueno
Frontiers in Immunology|December 6, 2021
The Leptin Axis and Its Association With the Adaptive Immune System in Breast CancerLaura García-Estevez, Silvia González-Martínez, Gema Moreno-Bueno
Molecular Oncology|June 8, 2017
EMT: Present and future in clinical oncologyPatricia G Santamaria, Gema Moreno-Bueno, Francisco Portillo, et al.
Pageof 14